Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/15/22 19:00 | 3/14/22 | STRO | Health | BioPrd | Biological Products, (No Diag | Newell William J | CA | DO | CEO | P | 78 | 7.75 | 0 | 10 | 4 | 241 | I | ||||||||||||||
5/14/20 17:29 | 5/14/20 | STRO | Health | BioPrd | Biological Products, (No Diag | Newell William J | CA | DO | CEO | P | 500 | 7.75 | 0 | 65 | 46 | 203 | D | ||||||||||||||
5/14/20 17:27 | 5/14/20 | STRO | Health | BioPrd | Biological Products, (No Diag | Molina Arturo Md | CA | O | Chief Me | P | 50 | 7.75 | 0 | 6 | 115 | 12 | D | ||||||||||||||
5/14/20 17:26 | 5/14/20 | STRO | Health | BioPrd | Biological Products, (No Diag | Fitzpatrick Linda A | CA | O | Chief Pe | P | 25 | 7.75 | 0 | 3 | 20 | 19 | D | ||||||||||||||
10/2/18 14:31 | 10/1/18 | STRO | Health | Drug | Pharmaceutical Preparations | Merck & Co., Inc. | NJ | T | P.d | 10,000 | 15.00 | 0 | 667 | 32 | 2,724 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |